These were: transition to insulin (encompassing aspects related to patient knowledge, readiness, and the psychological impact on both patients and caregivers); social challenges (including emotional support and addressing stigma); and healthcare services (with a specific focus on age-appropriate diabetes services. This evidence concerns the gene INS and diabetes mellitus.